DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dilaudid (Hydromorphone Hydrochloride) - Indications and Dosage

 


Nutrilib.com
A comprihensive source of nutritional information

INDICATIONS AND USAGE

DILAUDID ORAL LIQUID and DILAUDID 8 mg TABLETS are indicated for the management of pain in patients where an opioid analgesic is appropriate.

DOSAGE AND ADMINISTRATION

Dilaudid Oral Liquid

The usual adult oral dosage of DILAUDID ORAL LIQUID is one-half (2.5 mL) to two teaspoonfuls (10 mL) (2.5 mg - 10 mg) every 3 to 6 hours as directed by the clinical situation. Oral dosages higher than the usual dosages may be required in some patients.

Dilaudid 8 Mg Tablet

The usual starting dose for DILAUDID tablets is 2 mg to 4 mg, orally, every 4 to 6 hours. Appropriate use of the DILAUDID 8 mg TABLET must be decided by careful evaluation of each clinical situation.

A gradual increase in dose may be required if analgesia is inadequate, as tolerance develops, or if pain severity increases. The first sign of tolerance is usually a reduced duration of effect.

SAFETY AND HANDLING INSTRUCTIONS

DILAUDID ORAL LIQUID and DILAUDID 8 mg TABLETS pose little risk of direct exposure to health care personnel and should be handled and disposed of prudently in accordance with hospital or institutional policy. Significant absorption from dermal exposure is unlikely; accidental dermal exposure to DILAUDID ORAL LIQUID should be treated by removal of any contaminated clothing and rinsing the affected area with cool water. Patients and their families should be instructed to flush any DILAUDID ORAL LIQUID and DILAUDID 8 mg TABLETS that are no longer needed.

Access to abusable drugs such as DILAUDID ORAL LIQUID and DILAUDID 8 mg TABLETS presents an occupational hazard for addiction in the health care industry. Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers. Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by health care providers.

HOW SUPPLIED

DILAUDID ORAL LIQUID is a clear, sweet, slightly viscous liquid. It is available in: Bottles of 1 pint (473 mL) - NDC# 0074-2452-02

DILAUDID 8 mg TABLETS are white and triangular shaped, embossed with the number 8 on one side and bisected and embossed with a double Abbott “A” logo on the other side. They are available in: Bottles of 100 - NDC# 0074-2426-14

STORAGE

Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). [See USP Controlled Room Temperature]. Protect from light.

A schedule CS-II Narcotic. DEA Order Form is Required.

©Abbott

All rights reserved.

Abbott Laboratories, North Chicago, IL 60064, USA

Page last updated: 2006-02-17

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008